Integral Ad Science (NASDAQ:IAS) Trading Down 4.7%

Integral Ad Science Holding Corp. (NASDAQ:IAS) shares dropped 4.7% during trading on Wednesday . The stock traded as low as $10.22 and last traded at $10.25. Approximately 394,167 shares were traded during trading, a decline of 77% from the average daily volume of 1,685,301 shares. The stock had previously closed at $10.76.

Analyst Ratings Changes

IAS has been the topic of several recent research reports. Benchmark reaffirmed a “hold” rating on shares of Integral Ad Science in a report on Tuesday, May 7th. Barclays lowered their target price on shares of Integral Ad Science from $16.00 to $12.00 and set an “equal weight” rating on the stock in a report on Monday, April 15th. Morgan Stanley lifted their price objective on shares of Integral Ad Science from $12.00 to $13.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 23rd. Raymond James decreased their price objective on shares of Integral Ad Science from $16.00 to $13.00 and set an “outperform” rating on the stock in a research note on Friday, May 10th. Finally, Loop Capital started coverage on shares of Integral Ad Science in a research note on Tuesday, April 30th. They set a “buy” rating and a $15.00 target price on the stock. Three equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to MarketBeat.com, Integral Ad Science presently has a consensus rating of “Moderate Buy” and an average price target of $16.33.

Integral Ad Science Stock Down 5.4 %

The company has a debt-to-equity ratio of 0.13, a quick ratio of 4.32 and a current ratio of 4.32. The firm has a market capitalization of $1.63 billion, a PE ratio of 1,018.00, a PEG ratio of 1.85 and a beta of 1.53. The company’s 50 day simple moving average is $9.79 and its 200-day simple moving average is $11.05.

Integral Ad Science (NASDAQ:IAS) last posted its earnings results on Thursday, May 9th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01). Integral Ad Science had a net margin of 0.59% and a return on equity of 0.32%. The business had revenue of $114.50 million for the quarter, compared to analysts’ expectations of $112.12 million. During the same period in the prior year, the company posted $0.02 EPS. The business’s revenue for the quarter was up 7.9% compared to the same quarter last year. On average, analysts forecast that Integral Ad Science Holding Corp. will post 0.22 EPS for the current fiscal year.

Insider Activity

In related news, CEO Lisa Utzschneider sold 8,044 shares of Integral Ad Science stock in a transaction on Monday, May 6th. The shares were sold at an average price of $9.97, for a total value of $80,198.68. Following the transaction, the chief executive officer now owns 203,139 shares in the company, valued at approximately $2,025,295.83. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other Integral Ad Science news, CAO Alexis Gil II sold 2,792 shares of Integral Ad Science stock in a transaction dated Tuesday, June 4th. The shares were sold at an average price of $9.09, for a total value of $25,379.28. Following the completion of the transaction, the chief accounting officer now directly owns 145,550 shares of the company’s stock, valued at $1,323,049.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Lisa Utzschneider sold 8,044 shares of the business’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $9.97, for a total transaction of $80,198.68. Following the sale, the chief executive officer now owns 203,139 shares of the company’s stock, valued at $2,025,295.83. The disclosure for this sale can be found here. In the last quarter, insiders have sold 22,478 shares of company stock worth $218,311. 2.00% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Integral Ad Science

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Ameritas Investment Partners Inc. raised its stake in Integral Ad Science by 40.1% during the first quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock valued at $67,000 after purchasing an additional 1,924 shares in the last quarter. ProShare Advisors LLC purchased a new stake in Integral Ad Science during the first quarter valued at $121,000. American Trust raised its stake in Integral Ad Science by 18.0% during the first quarter. American Trust now owns 13,742 shares of the company’s stock valued at $137,000 after purchasing an additional 2,096 shares in the last quarter. Vontobel Holding Ltd. purchased a new stake in Integral Ad Science during the fourth quarter valued at $176,000. Finally, Price T Rowe Associates Inc. MD raised its stake in Integral Ad Science by 55.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 19,215 shares of the company’s stock valued at $192,000 after purchasing an additional 6,878 shares in the last quarter. Institutional investors own 95.78% of the company’s stock.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.